NCT02446977View on ClinicalTrials.gov

Administration of CBG000592 (Riboflavin/Vitamin B2) in Patients With Acute Ischemic Stroke

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Ischemic Stroke
Interventions
DRUG

Vitamin B2 Streuli®

4ml IV

OTHER

Solution for injection

4ml IV

Trial Locations (1)

15706

Complejo Hospitalario Universitario de Santiago, Santiago de Compostela

All Listed Sponsors
lead

Castillo, José, M.D.

INDIV

NCT02446977 - Administration of CBG000592 (Riboflavin/Vitamin B2) in Patients With Acute Ischemic Stroke | Biotech Hunter | Biotech Hunter